|
|
Volumn 5, Issue 3, 2008, Pages 117-132
|
|
Guidelines for diagnosis and treatment of carcinoma of the esophagus: April 2007 edition: Part II edited by the Japan Esophageal Society
a a a a a a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CISPLATIN;
DOCETAXEL;
DOXORUBICIN;
FLUOROURACIL;
GEMCITABINE;
IRINOTECAN;
MITOMYCIN C;
NAVELBINE;
NEDAPLATIN;
PACLITAXEL;
VINBLASTINE;
VINDESINE;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
BONE MARROW SUPPRESSION;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER CONTROL;
CANCER DIAGNOSIS;
CANCER MORTALITY;
CANCER PALLIATIVE THERAPY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL TRIAL;
COMPRESSION FRACTURE;
CONTINUOUS INFUSION;
ESOPHAGEAL ADENOCARCINOMA;
ESOPHAGEAL SQUAMOUS CELL CARCINOMA;
ESOPHAGITIS;
ESOPHAGUS PERFORATION;
ESOPHAGUS RESECTION;
ESOPHAGUS STENOSIS;
FOLLOW UP;
HUMAN;
JAPAN;
LYMPH NODE METASTASIS;
MONOTHERAPY;
MULTIMODALITY CANCER THERAPY;
MULTIPLE CYCLE TREATMENT;
MYELITIS;
NAUSEA;
PERICARDIAL EFFUSION;
PERICARDITIS;
PLEURA EFFUSION;
PLEURISY;
POSTOPERATIVE CARE;
PRACTICE GUIDELINE;
PREOPERATIVE CARE;
PRIORITY JOURNAL;
RADIATION DERMATITIS;
RADIATION DOSE;
RADIATION DOSE FRACTIONATION;
RADIATION PNEUMONIA;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT CANCER;
REVIEW;
SALVAGE THERAPY;
SURVIVAL RATE;
TREATMENT INDICATION;
TREATMENT PLANNING;
TREATMENT RESPONSE;
TUMOR VOLUME;
UNSPECIFIED SIDE EFFECT;
VOMITING;
|
|
EID: 52149089919
PISSN: 16129059
EISSN: 16129067
Source Type: Journal
DOI: 10.1007/s10388-008-0158-8 Document Type: Review |
|
Times cited : (27)
|
|
References (0)
|